| 000 | 00000nam 2200000za 4500 |
| 001 | 9.698787 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20220107103659 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407s2014||||xxc|||||o f|0| 0 eng d |
|---|
| 020 | |a978-1-100-23147-1 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-94/2014E-PDF |
|---|
| 110 | 2 |aCentre for Infectious Disease Prevention and Control (Canada) |
|---|
| 245 | 10|aUpdate on the use of pneumococcal vaccines |h[electronic resource] : |baddition of asthma as a high-risk condition. |
|---|
| 246 | 1 |iAt head of title: |aAdvisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI) |
|---|
| 260 | |aOttawa - Ontario : |bPublic Health Agency of Canada. |cFebruary 2014. |
|---|
| 300 | |a27p.|breferences, tables |
|---|
| 590 | |a14-08|b2014-02-21 |
|---|
| 690 | 07|aImmunization|2gcpds |
|---|
| 775 | 08|tMise à jour sur l’utilisation des vaccins antipneumococciques |w(CaOODSP)9.642788 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s620 KB|uhttps://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-94-2014-eng.pdf |
|---|